Trump's FDA Pick was Chosen to Overrule America's Doctors
Heidi Overton called the fall of Roe "a huge victory for life" and pushed the FDA to ban access to medication abortion
WASHINGTON, DC –– President Trump is tapping Dr. Heidi Overton, the deputy director of his Domestic Policy Council, to run the Food and Drug Administration — the agency that decides which medications America's doctors are permitted to prescribe. Overton celebrated the overturning of Roe v. Wade as "a huge victory for life," dismissed federal legislation protecting abortion rights as "radicalism," and has promoted false claims about the safety of medication abortion that contradict more than two decades of evidence.
Mifepristone is a safe, effective FDA-approved medication used for early abortion and is now used in more than half of all abortions. Mifepristone is also recommended by the American College of Obstetricians and Gynecologists (ACOG) for use in miscarriage management. If left untreated, miscarriage can put women at risk for severe infection, infertility, or even death.
Before joining the White House, Overton was chief policy officer at the America First Policy Institute, when the organization called on the FDA to reinstate in-person dispensing requirements for mifepristone, prohibit telehealth prescribing outright, and mandate in-person ultrasounds. She has also argued that the FDA, NIH, and CDC should be remade for failing to fund research aligned with conservative views.
She would inherit an agency with no confirmed leader since May, when Commissioner Marty Makary resigned under sustained pressure from anti-abortion groups who spent months publicly demanding he be fired for refusing to move faster on restricting mifepristone. The message to physicians is not subtle: the last FDA commissioner lost his job for failing to override the medical evidence fast enough, and the next one is walking in with the assignment already written.
What this nomination means for doctors and their patients:
The FDA commissioner personally controls whether a physician may prescribe abortion medication by telehealth or must force every patient into an in-person visit. HHS ordered a review of the mifepristone REMS in September 2025 — the review Makary was pushed out over — and it would land on Overton's desk.
The American Medical Association has been unequivocal: serious adverse events occur in fewer than one-third of one percent of patients, and continuing a pregnancy carries roughly 14 times the risk of death. Reimposing in-person requirements, the AMA warns, would eliminate telehealth for rural, low-income, and underserved patients and force doctors to deliver worse care.
In February 2026, ACOG led a coalition of 15 medical organizations in defending mifepristone's safety record in court. There is no meaningful dispute among the physicians who actually prescribe this medication — only among the political appointees who want to take it away from them.
Medication abortion accounted for 65% of all U.S. abortions, and more than one in four clinician-provided abortions were delivered by telehealth as of December 2025. A single decision by this FDA commissioner reaches into the exam room of every one of those patients.
Doctors are already leaving. Idaho lost 35% of its obstetric providers between August 2022 and December 2024, and a March 2026 study in JAMA Network Open found applications to residency programs in ban states dropped 4.2% in a single cycle. A hostile FDA accelerates a physician shortage that is already measurable.
This is not happening in isolation. On August 7, more than 30 anti-abortion organizations asked the attorney general to invoke the Comstock Act to halt the mailing of abortion medication nationwide. A friendly FDA commissioner is the other half of that strategy.
Gowri Buddiga, Campaign Director for Free & Just released the following statement on the nomination of Dr. Heidi Overton to lead the FDA:
“Heidi Overton is a doctor being handed the FDA on the condition that she overrule doctors. Her predecessor was forced out for refusing to move fast enough against a medication every major medical group calls safe. That is not a safety review. That is a political errand wearing a white coat. When you don't trust a diagnosis, you get a second opinion. America's doctors have one: no on Overton. We will make sure the Senate hears it before a single vote is cast.”
Bottom Line: The FDA commissioner does not just regulate medication — she decides whether your doctor is allowed to give it to you. Trump has chosen a nominee whose central qualification for the job is her willingness to say no.
If you are interested in connecting with patients, physicians, or advocates about what Overton’s nomination means for doctors and patients across the country, including those living in states where abortion is currently protected, please contact kelly@freeandjust.us.
###
Free & Just is fighting to stop attacks on reproductive freedom and rights. We’re working with people across the country to share real stories to show the devastating consequences of attacks on our reproductive freedom. We all deserve the right to control our bodies and lives. That’s why we’re sharing our stories, raising our voices, and fighting for our future.